Follow-Up Of Patients Undergoing CAR T Cell Therapy – New Tools For Immune Monitoring

CAR T cell therapy has emerged as an important therapeutic option for hematological malignancies. A sensitive follow-up of patients undergoing CD19-targeted CAR T cell therapy is important to analyze. Furthermore, downstream analysis of CAR T cells isolated from the patient’s blood could help identify factors that distinguish responders from non-responders. In this webinar, Prof. Boris Fehse from the University Clinic Hamburg-Eppendorf and Dr. Thomas Stübig from the University Clinic Kiel will give insights into their work.